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Summary
AIMS OF THE STUDY: Induction of labour after previous
caesarean section (CS) is a challenge for obstetricians
due to the increased risk of uterine rupture. Common
methods for labour induction are balloon catheters and
oxytocin as they are considered safe. However, the effec-
tiveness remains unclear as currently available data are
limited. Therefore, we aimed to determine safety and ef-
fectiveness of balloon catheter or oxytocin for labour in-
duction after CS.
METHODS: We included 179 consecutive women with
a previous CS and labour induction in this retrospective
study. We performed labour induction using a balloon
catheter in case of a Bishop score of <6 and intact mem-
branes, or oxytocin in the case of a Bishop score of >6
and/or premature rupture of membranes. The primary out-
come was the rate of successful vaginal deliveries. We ad-
justed for multiple factors that may have impacted on the
rate of vaginal delivery as well. The secondary outcomes
were the rate of maternal and neonatal morbidities.
RESULTS: We detected a vaginal delivery success rate
of 45.8% in the catheter and of 63.9% in the oxytocin
group. We identified previous vaginal birth as an inde-
pendent predictive factor for successful vaginal delivery in
both groups. Induction using oxytocin was a negative pre-
dictive factor for neonatal admissions. Multivariate analy-
sis showed that post-term pregnancy decreased the like-
lihood of vaginal delivery. We did not detect any factors
predicting uterine rupture or uterine dehiscence, which oc-
curred with similar frequency in both groups. Finally, the
neonatal admission rate was less likely with higher gesta-
tional age and oxytocin as an induction method, whereas
previous vaginal birth increased the risk.
CONCLUSIONS: Our study indicates that induction of
labour with balloon catheter or oxytocin seems to be safe
in women with previous CS. Labour induction using a
balloon catheter in women with previous CS and un-
favourable cervix has a disappointingly low success rate.
We identified factors influencing vaginal delivery success
rates. Women with previous CS and indications for labour
induction should be informed about vaginal birth success
rates and the alternative of elective repeat CS needs to be
discussed.
Key words: caesarean section, vaginal birth after cae-
sarean (VBAC), induction of labour, balloon catheter
Introduction
The caesarean section (CS) rate is increasing. Several fac-
tors are contributing to rising CS rates with previous CS
being important among these [1, 2]. The dogma “once a
caesarean – always a caesarean” [3] existed in the 1970s,
and public health authorities and obstetric societies tried
to reverse the trend by promoting vaginal birth after cae-
sarean (VBAC). These efforts led to a sharp increase in the
VBAC prevalence to approximately 30% in the US in the
late 1990s [4]. However, large retrospective studies have
showed a small but significant increase in adverse neona-
tal outcomes and perinatal death in VBAC compared to
repeated CS [5]. As a consequence, the VBAC trend re-
versed rapidly and VBAC prevalence has dropped below
10% in the US.
Despite this trend, VBAC may be safe for many women
and an individual risk-benefit analysis is necessary. This
is particularly important if labour induction is performed
as in case of approximately 20% of women attempting
VBAC [4, 6]. This continuing debate is further heated up
as the Royal College of Obstetricians and Gynaecologists
and the American College of Obstetricians and Gynecol-
ogists disagree about the safety of labour induction using
prostaglandins after CS [4–10]. Therefore, counselling our
patients about labour induction and management strategies
is difficult. Furthermore, patients attempting labour induc-
tion after CS should be offered not only a safe, but also an
effective method [11]. In general, labour induction can be
achieved by using several approaches.
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Prostaglandins (PGE2) are an effective tool for cervix
ripening and induction of labour. However, in the case of
VBAC, higher uterine rupture rates compared to sponta-
neous onset of labour, amniotomy and/or oxytocin were
noted [12]. Misoprostol is very effective, but generally
contraindicated in women with previous CS due to a high
uterine rupture risk. Given the higher uterine rupture risk,
the use of prostaglandins for labour induction after CS is
not used in our institution [7, 12, 13].
Oxytocin administration is considered a safe method, but
may be less effective with an unfavourable Bishop score
[14]. An eligible alternative is mechanical induction of
labour using a balloon catheter (single or double balloon
device). Although this method is widely used, available
data on safety and effectiveness after labour induction is
scarce [15–17]. Given that balloon catheters and oxytocin
are valid options for labour induction in patients attempt-
ing VBAC and have lower uterine rupture risk [18], we
performed a retrospective cohort study to assess the safety
and effectiveness of labour induction after CS using bal-
loon catheters or oxytocin. Given that multiple factors may
influence VBAC success, we aimed to determine single
and multi-variant parameters in our cohort as well [19].
Material and methods
We performed a retrospective cohort study at our tertiary
referral centre at the University Hospital of Bern. We in-
cluded all consecutive singleton pregnancies delivered be-
tween January 2003 and December 2014 who underwent
VBAC and labour induction after 24 weeks of gestation.
We excluded all pregnancies with lethal congenital anom-
alies and pregnancies with antepartum intrauterine fetal
demise, as well as patients with additional surgical proce-
dures that led to opening of the uterine cavity, such as my-
omectomy. Importantly, patients with spontaneous onset of
labour were not taken into consideration.
We performed labour induction either by using a tran-
scervical balloon catheter for cervical ripening, or by ad-
ministrating oxytocin, depending on the Bishop score and
membrane rupture status. The Bishop score is an obstetric
cervix scoring method assessing the following parameters
on digital vaginal examination: cervical dilation, efface-
ment, position and consistency, and fetal position. It is an
accurate, cost- effective cervical evaluation method pri-
or to induction of labour [20]. In patients with a Bishop
score > 6 with intact membranes or with ruptured mem-
branes, we used oxytocin. We administrated 5 IU oxytocin
in 500 ml of a sodium chloride and glucose solution as fol-
lows: begin with 12 ml/h and increase the dosage every 15
minutes by 21ml/h until development of regular contrac-
tions or until reaching the maximum dosage of 120 ml/h,
for maximum of 6 hours. In patients with a Bishop score
<6 and intact membranes, we inserted the balloon catheter
transcervically and inflated it with sterile 0.9% saline solu-
tion (60 ml in the single balloon Foley catheter and max-
imum 80 ml in each balloon of a double device Cook®
catheter). There was no traction applied on the catheter.
The catheter remained in place until spontaneously ex-
pelled or until start of active labour. If neither happened,
the catheter was removed after 24 hours and oxytocin was
administered. If the cervix remained unfavourable after 6
hours of oxytocin infusion, induction was classified as un-
successful and subsequently CS was performed. Artificial
rupture of membranes (ARM) was performed whenever
technically feasible and progressive cervical dilatation was
missing. We performed ARM by using an amniotic mem-
brane perforator. We are aware that other centres have dif-
ferent internal guidelines or use different techniques and
protocols for the induction of labour after CS, so the results
may have a limited external validity.
The primary outcome of the study was successful vaginal
delivery, either spontaneous or assisted. We defined as-
sisted vaginal delivery as vaginal delivery using vacuum
or forceps. Spontaneous and assisted delivery were also
assessed as independent outcomes in the subsequent sta-
tistical analysis. Secondly, we evaluated the incidence of
maternal and fetal adverse outcomes as well as the influ-
ence of maternal factors on the delivery mode. We as-
sessed the following maternal data: maternal age, gesta-
tional age at the point of labour induction, parity, previous
vaginal delivery, indications for labour induction and pre-
vious CS, and need for oxytocin infusion during labour. We
assessed the following adverse maternal outcomes: intra-
partum infection and postpartum haemorrhage, defined as
a total blood loss of >500 ml in the case of vaginal deliv-
ery and a total blood loss of >1000 ml in the case of CS.
In addition, we defined uterus rupture as the uterus con-
tent reaching the abdominal cavity. The uterine dehiscence
(“incomplete” uterine rupture) was noted when the surgeon
identified a thin or incomplete uterine rupture (absence of
myometrium between the amniotic membrane and peri-
toneum). We assessed the following fetal outcomes: fetal
weight, APGAR score after 5 minutes, arterial pH values
and neonatal admission after birth. We divided the correla-
tions into clinically significant and non-significant. Clini-
cally non-significant correlations were defined as correla-
tions having no impact on the decision process (induction
of labour after CS). One example is the risk of “no per-
ineal laceration”, as this is not the primary goal of labour
induction. Another example is the fetal weight. It is expect-
ed that the fetal weight is higher if we induce labour due to
post-term pregnancy.
The study was approved by the Ethics Committee of the
Canton of Bern.
To calculate the impact of the induction method on deliv-
ery mode, we used Fisher's exact test. To obtain a confi-
dence interval for the true log-odds ratio, we calculated the
log-odds ratio for 10,000 bootstrap replicates. To detect in-
dividual correlations (one-to-one correlations), both with-
in the predictive variables and between the predictive and
outcome variables, we fitted a simple generalised linear
model (glm) for each variable pair, where one variable is
the dependent and the other the independent. Notably, us-
ing glms allows assessment of correlations between both
numerical and categorical variables. Each model obtained
was compared using a χ2-test to a null model that only
assumes a constant value for the dependent variable. The
resulting p-value was corrected for multiple testing using
the Benjamini-Hochberg method. Only correlation models
with an adjusted p-value of 0.01 were retained. Finally, we
used a compound model to determine which combinations
of predictive variables gave the best prediction for each of
the outcome variables. This analysis revealed more subtle
correlations that were not selected by the one-to-one analy-
sis. We accomplished this analysis by matching all models
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consisting of any combination of the predictive variables
for each outcome variable. We used the glmulti package
[21] to fit and evaluate all possible models. The perfor-
mance of each model was evaluated using the corrected
Akaike information criterion [22]. For each outcome vari-
able, the best performing model was selected and a p-val-
ue was calculated by comparing it against a null-model,
as described above. Evaluating each of the models using a
p-value was necessary as there was no guarantee that the
model with the best AICC score would perform better than
the null model. The p-values obtained were again corrected
using the Benjamini-Hochberg method and only the mod-
els with a corrected p-value of 0.01 were retained. The re-
sults were presented using network visualisation to obtain
a comprehensive overview of all the correlations that were
detected during this analysis.
Results
Patients’ basic characteristics
We summarised the patients’ basic characteristics in table
1. Given that the two patient groups investigated (induc-
tion using oxytocin or balloon catheter) are primarily de-
fined by the Bishop score and membrane-rupture status,
we detected differences between the two groups in terms
of basic characteristics. For example, multiparous women
were more common in the oxytocin group than in the
catheter group. Birth weight was higher in the catheter
group than in the oxytocin group, as the main indication
for catheter induction was post-term pregnancy. Although
a direct comparison between these groups is not possible,
the safety and effectiveness of labour induction after CS
can still be assessed.
Impact of the induction method on delivery mode
The main goal of our study was to determine the success
rate of vaginal delivery after induction of labour (balloon
catheter or oxytocin) in women with a scarred uterus. The
secondary goal was to detect factors that may influence the
delivery mode as well as multiple parameters relating to
maternal and neonatal outcomes.
As summarised in table 1, we detected a vaginal delivery
success rate of 63.9% (46/72) in the oxytocin group, which
is in line with previous reports [15, 19, 23]. In the catheter
group, we detected a success rate of 45.8% (49/107), which
was lower than expected [15, 23–25].
Maternal and fetal outcomes are summarised in table 1 as
well. We detected uterine rupture of 0.9% (1/107) in the
catheter and 1.4% (1/72) in the oxytocin group. The in-
complete uterine rupture (uterine dehiscence) was 4.67%
(5/107) in the catheter group and 5.55% (4/72) in the oxy-
tocin group. Notably, neither of these observations was sig-
nificant. The neonatal admission rate was 6.54% (7/107) in
the catheter, and 13.88% (10/72), in the oxytocin group.
One-to-one correlations and delivery mode
To further dissect which factors contribute to the vaginal
delivery success rate, we searched for one-to-one correla-
tions. We detected several apparent and clinically not sig-
nificant one-to-one correlations such as fetal weight and
gestational age, or gestational age and post-term pregnancy
(table 2 and fig. 1 solid lines). Premature rupture of mem-
branes (PROM) as an indication for labour induction cor-
related positively with oxytocin as an induction method
Table 1: Patient’s basic characteristics and materno-fetal outcomes in
the cohorts (induction method catheter and oxytocin after caesarean
section).
Catheter group Oxytocin group
Patients’ basic characteristics
Age (years), mean (SD) 33.19 (± 4.77) 31.83 (± 4.99)
Gestational age (weeks/
days), mean (SD)
40.26 (± 1.30) 38.70 (± 2.74)
At least one prior vaginal de-
livery, n (%)
22 (20.56%) 19 (26.38%)
Primiparous (has given birth
only once), n (%)
85 (79.43%) 53 (73.61%)
Multiparous (has given birth
more than once), n (%)
22 (20.6%) 19 (26.38%)
Grand multipara (has given
birth at least five times), n
(%)
2 (1.86%) 0 (0.00%)
Duration between previous
CS and induction of labour
(years), mean (SD)
4.19 (± 3.35) 4.53 (± 3.25)
Maternal and neonatal outcomes
Vaginal delivery, n (%) 49 (45.79%) 46 (63.88%)
Caesarean section, n (%) 58 (54.21%) 26 (36.12%)
Vaginal assisted delivery, n
(%)
12 (16.66%) 12 (16.66%)
Episiotomy, n (%) 17 (15.88%) 15 (20.83%)
High-grade perineal lacera-
tion (3 and 4), n (%)
4 (3.73%) 1 (1.38%)
Cervical laceration, n (%) 0 (0.00%) 1 (1.38%)
Peridural anaesthesia, n (%) 43 (40.18%) 35 (48.61%)
Uterine rupture, n (%) 1 (0.93%) 1 (1.38%)
Uterine dehiscence, n (%) 5 (4.67%) 4 (5.55%)
Birth weight (g) mean (SD) 3515.83 (±
464.73)
3206.25 (± 659.47)
Birth weight > 4000 g, n (%) 11 (10.28%) 6 (8.33%)
APGAR-score after 5 min-
utes mean (SD)
8.88 (± 0.73) 8.60 (± 1.00)
APGAR-Score < 7, n (%) 0 (0.00%) 2 (2.77%)
pH mean (SD) 7.24 (± 0.07) 7.26 (±0.071)
pH <7.20, n (%) 21 (19.62%) 8 (11.11%)
pH <7.00, n (%) 1 (0.93%) 0 (0.0%)
Neonatal admissions, n (%) 7 (6.54%) 10 (13.88%)
Indication(s) of labour induction*
Post-term, n (%) 43 (40.18%) 15 (20.83%)
Gestational hypertension/
preeclampsia, n (%)
7 (6.54%) 0 (0.00%)
Oligo-/polyhydramnios, n
(%)
9 (8.41%) 1 (1.38%)
Pregnancy cholestasis, n
(%)
6 (5.60%) 1 (1.38%)
Patient’s request, n (%) 13 (12.14%) 2 (2.77%)
(Gestational) diabetes, n (%) 14 (13.08%) 3 (7.14%)
Fetal distress, n (%) 4 (3.73%) 4 (5.55%)
PROM/PPROM, n (%) 2 (1.86%) 42 (58.33%)
Others, n (%) 9 (8.41%) 4 (5.55%)
Indication for previous CS*
Failed induction of labour, n
(%)
5 (4.67%) 2 (2.77%)
Labour dystocia, n (%) 11 (10.28%) 7 (9.72%)
Abnormal progression of
labour, n (%)
18 (16.82%) 10 (13.88%)
Fetal distress, n (%) 21 (19.62%) 17 (23.61%)
Breech presentation, n (%) 16 (14.95%) 12 (16.66%)
Others, n (%) 25 (23.36%) 16 (22.22%)
Unknown 13 (12.14%) 8 (11.11%)
* (some cases with multiple indications)
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as well. Importantly, we detected two clinically significant
correlations: previous vaginal birth as a single predictive
factor for vaginal delivery (independent of induction
method) and induction method (oxytocin) as a negative
predictive factor for neonatal admissions (see fig. 1 full
lines). To further dissect which variables (multiple) predict
vaginal birth success rate and impact on outcomes (neona-
tal and maternal), we used a compound model.
Multiple correlations and materno-fetal outcomes
Figure 2 (dashed lines) summarises all the detected and
significant multiple correlations in our cohort. To under-
stand the impact of the data on clinical practice, we divided
it into clinically significant (table 3) and clinically not sig-
nificant correlations (supplementary table S1 in appendix
1). Notably, the coefficient describes a positive or negative
impact of the variables. Indeed, vaginal delivery success
was more likely if previous vaginal delivery was noted and
oxytocin as the induction method used. Additionally, post-
term pregnancy as an indication for labour induction and
other reasons for previous CS decreased the likelihood of
vaginal delivery success. Interestingly, vaginal operative
delivery was more likely if previous CS was performed
due to abnormal labour progression or labour dystocia,
whereas oxytocin as an induction method and previous
vaginal birth decreased this likelihood. These observations
suggest that previous vaginal birth process impact on the
vaginal success rate in current pregnancy.
We identified single and multiple factors impacting on the
VBAC success rate. Previous vaginal delivery and oxy-
tocin as the induction method are the most prominent.
Discussion
We report that, in our cohort, induction of labour with oxy-
tocin seems to be a safe method. It also seems to be an
effective method for women with previous CS and a po-
Table 2: Significant one-to-one correlations in the investigated cohorts (induction method catheter and oxytocin after caesarean section).
Variable 1 Variable 2 Coefficient p-value Adj. p-value
Fetal weight (g) Gestational age (days) 182.422 2.21E-34 1.12E-31
Gestational age (days) Induction because post-term pregnancy 2.634 1.71E-23 4.33E-21
Induction method oxytocin Induction because PROM 4.356 3.13E-20 5.27E-18
Gestational age (days) Induction because PROM -2.572 1.13E-16 1.43E-14
Fetal weight (g) Induction because PROM -570.658 1.25E-10 1.27E-08
Fetal weight (g) Induction because post-term pregnancy 462.599 1.56E-08 1.32E-06
Gestational age (days) Induction method oxytocin -1.497 7.87E-07 5.69E-05
Induction method oxytocin Induction because other -1.47 8.90E-05 5.25E-03
Previous vaginal birth Perineal laceration none -1.501 9.33E-05 5.25E-03
Induction method oxytocin Neonatal admission -1.388 1.51E-04 7.50E-03
Previous vaginal birth Perineal laceration I° 1.695 1.68E-04 7.50E-03
Delivery mode: vaginal Previous vaginal birth 1.443 1.78E-04 7.50E-03
Fetal weight (g) Induction method oxytocin -309.582 2.29E-04 8.91E-03
Figure 1: All significant one-to-one correlations in the cohorts (induction method catheter and oxytocin after caesarean section; for
details see table 2). Each edge represents a statistically significant relationship between two variables. Positive correlations are indicated by
the colour green (for example the gestational age correlates positively with the fetal weight: the more advanced the gestational age, the higher
the fetal weight). Negative correlations are indicated by the colour red (for example, labour induction because of PROM is correlated to a lower
birth weight). Predictive variables (factors) are indicated with circles and outcome variables with squares (for example induction because post-
term pregnancy is a predictive factor for higher fetal weight). The size of the squares reflects the overall significance.
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tential alternative to repeated CS. We detected a VBAC
success rate of 63.9% when oxytocin was used, which is
in line with previous reports [15, 19, 23]. Further, induc-
tion with a balloon catheter seems to be safe as well, but
associated with a lower vaginal delivery success rate of on-
ly 45.8%. However, almost half of our patients delivered
vaginally. Depending on a patient’s preference, this pre-
sents a valid basis for repeated CS. As many healthcare
providers offer primary CS to patients with unfavourable
Bishop scores, and increase the CS rate unnecessarily as
a result, our study provides support that induction using
oxytocin or balloon catheter is possible. We are aware that
a direct comparison between the groups is limited due to
different inclusion criteria. However, patients attempting
VBAC need to be counselled about the advantages and
disadvantages prior to labour induction. Often, the cervi-
cal ripening score is not available at the initial counselling
time point, but all potential options and success rates need
to be addressed. We are aware that other centres have dif-
ferent internal guidelines or use different techniques and
protocols for the induction of labour after CS, so the results
may have a limited external validity.
An unexpected finding in our study was that the vaginal
delivery success rate in the catheter group was lower com-
pared to previous studies [23–26]. Nevertheless, a recent
study reported a vaginal delivery success rate after catheter
induction in women with unfavourable cervix of approxi-
mately 50%, which is in line with our results [17]. These
various success rates suggest that multiple factors need to
be accounted for prior to labour induction. Factors that
may impact on VBAC success rate are fetal weight, mater-
nal age, indication for previous CS, or previous vaginal de-
livery [3, 27]. In our cohort, previous vaginal delivery had
the biggest impact on vaginal delivery success rate (fig. 1:
one-to-one correlation solid line and fig. 2: multiple corre-
lations dashed lines). This is in line with previous reports
showing that previous vaginal delivery is the most impor-
tant success predictor for VBAC success, whereas labour
dystocia as a previous CS indication represent a negative
prediction factor [28]. Interestingly, abnormal labour pro-
gression and labour dystocia as indications for previous CS
did not impact the CS rate in our cohort, but rather in-
creased assisted vaginal operative delivery rates (fig. 1 and
table 3). We hypothesise that this may be due to different
obstetric practices between institutions. Besides previous
vaginal delivery, oxytocin as an induction method increas-
es the likelihood of vaginal delivery as well. The question
of whether oxytocin should be applied only to a favourable
cervix is still unanswered, as a recent study reported a
higher vaginal delivery success rate compared to catheter
devices [17]. Additional prospective and multi-centre stud-
ies are necessary, especially as maternal morbidities such
as uterus rupture after oxytocin use were reported [29].
The safety of both the mother and neonate is the main goal
in patients attempting VBAC and labour induction. In our
cohort, we observed a higher incidence of neonatal admis-
sions after labour induction using oxytocin. However, (8/
10) neonatal admissions were due to premature rupture of
membranes (PROM), one due to fetal distress, and one due
to trisomy 21 and fetal distress, which explains the dif-
ferences. Notably, no long-term complications were noted.
Together, the neonatal admission rate confirms the impor-
tance of proper equipped perinatal units when labour is in-
duced after previous CS. It includes not only trained obste-
Figure 2: All significant and multiple correlations in the cohort. (Induction method catheter and oxytocin after caesarean section; for de-
tails see table 3 – clinically significant correlations and table S1 – clinically not relevant correlations). Each edge represents a statistically sig-
nificant relationship between multiple variables. Positive correlations are indicated by the colour green (for example, previous vaginal birth in-
creases the likelihood of vaginal delivery and a first degree perineal tear). Negative correlations are indicated by the colour red (for example,
previous vaginal birth decreases the likelihood of secondary CS and vaginal assisted delivery due to abnormal labour progression). Predictive
variables (factors) are indicated with circles and outcome variables with squares (for example higher gestational age results in increased fetal
weight and higher risk for secondary CS due to abnormal labour progression). The size of the squares reflects the overall significance. Finally,
variables related to the same indication or outcome variable (each reason for induction or type of perineal laceration) have the same node
colour.
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tricians but the timely availability of a neonatologist at the
unit as well.
The most severe maternal complication after labour induc-
tion on a scarred uterus is uterus rupture [27, 30–33]. Giv-
en increasing awareness of uterine dehiscence and/or thin
lower uterine segment after CS, we defined uterine rup-
ture and uterine dehiscence according to current standards.
Although our analyses did not detect any predicting fac-
tors associated with uterine rupture, there remains a con-
troversial discussion about the incidence of uterus rupture
after labour induction and spontaneous onset of birth [12,
18, 34–38]. There is always a small risk of uterine rupture
when VBAC is attempted. The risk in the case of spon-
taneous labour onset is approximately 0.5–0.7%, and in
the case of labour induction approximately 0.8% without
prostaglandins and 2.7% with prostaglandins compared to
repeat CS [12, 18]. Whether oxytocin or balloon catheter is
the safest choice is still unanswered by the present study,
mainly due to the rare occurrence of this event. In this re-
gard, an important problem is that the definition of “thin
uterine segment” or uterine dehiscence is not standardised.
In our cohort, the incidence of uterine rupture was rare and
Table 3: Detailed analysis of clinically significant compound models in
the cohorts investigated (induction method catheter and oxytocin after
caesarean section).
Variable p-value Coefficient
Significant variables imparting vaginal delivery
Induction method: oxytocin 1.69E-02 0.567




Previous caesarean section be-
cause: other
1.82E-02 -0.795
Significant variables imparting vaginal operative delivery be-
cause: other
Induction method oxytocin 7.73E-02 -38.211
Previous CS because: breech
presentation
5.02E-02 59.452
Previous CS because: labour
dystocia
2.23E-02 40.711
Previous CS because: abnor-
mal labour progression
1.66E-02 39.637
Significant variables imparting vaginal operative delivery be-
cause: abnormal labour progression
Induction method oxytocin 5.006E 1.366
Previous vaginal birth 1.47E-02 -18.129
Induction because: patients re-
quest
2.00E-01 -18.426
Previous CS because: breech
presentation
3.84E-02 -17.744
Previous CS because: labour
dystocia
1.15E-01 1.673
Significant variables imparting neonatal admission
Induction method oxytocin 1.51E-04 -3.339
Gestational age (days) 9.14E-07 -0.577
Previous vaginal birth 9.47E-02 0.821
Induction because: other 8.81E-02 -1.046
Previous caesarean section be-
cause: breech presentation
1.62E-03 1.46
Previous caesarean section be-
cause: labour dystocia
5.20E-02 -1.793
Significant variables imparting secondary CS because: abnor-
mal labour progression
Induction method oxytocin 1.55E-03 -1.054
Gestational age (days) 1.06E-02 0.384
Previous vaginal birth 1.63E-03 -2.358
comparable to previous studies [12, 13, 15, 19, 39]. How-
ever, thin uterine segment was noted to be more common
(table 1). We have to acknowledge that this study is not de-
signed to detect these kinds of changes. Besides its retro-
spective design, the patient inclusion timeline is the main
limitation of our study. For example, during the time in-
vestigated, we changed our internal guidelines from sin-
gle to double-device catheter, which may bias the internal
validity of our findings. Additionally, the number of pa-
tients induced using the double-balloon catheter was not
large enough to detect differences between single and dou-
ble balloon catheter devices. Studies comparing these two
catheter devices are needed [40]. Further limitations arise
due to the retrospective design of our study. For exam-
ple, certain factors that may have influenced the VBAC
success rate in our multivariate analysis were not present.
These include body-mass index, ethnicity, and exact Bish-
op score after 24h catheter induction. On the other hand,
the advantages of our study are the large total number of
patients included, the exclusion of patients with sponta-
neous onset of labour, and the single and multi-variant as-
sessment of factors contributing to VBAC success. Togeth-
er, our study provides important information contributing
to proper counselling of our patients.
Together, prior to labour induction, patients need to be
counselled extensively and included in the process of de-
cision making. Again, as in case of vaginal delivery suc-
cess rate, the patient population must be considered, and
additional factors assessed. These include indication(s) of
previous CS, previous vaginal birth, maternal age, or thick-
ness of the lower uterine segment measured by ultrasound
[9]. Importantly, patients need to be counselled not only
about the risks of VBAC, but also about the CS related
morbidities as well. These include infection, increased
blood loss, intraoperative lesions [41, 42], thromboembolic
events, and abnormal placentation risk in following preg-
nancies [43, 44].
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Appendix 1 Supplementary table
Table S1: Detailed analysis of clinically non-significant compound models in the investigated cohorts (induction method catheter and oxytocin after caesarean section).
Variable p-value Coefficient
Selected variables for the pHa model
Age (years) 5.840E-03 -0.003
Gestational age (days) 1.221E-01 -0.008
Induction because: of post term pregnancy 3.639E-02 0.028
Previous CS because: labour dystocia 4.088E-02 -0.040
Selected variables for the APGAR5 model
Age (years) 6.508E-02 -0.026
Gestational age (days) 1.796E-02 0.072
Induction because: diabetes 2.065E-02 0.477
Previous CS because: abnormal progression of labour 8.003E-02 0.311
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